Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04508205 · ClinicalTrials.gov registry record · Phase 1
CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes
A Phase 1 study, sponsored by CAGE Bio.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT04508205 is a Phase 1 study that has completed, run by CAGE Bio. The registered enrollment target is 27 participants.
The verdict
NCT04508205, a Phase 1 study, has completed, sponsored by CAGE Bio.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
Open-label multicenter study using CGB-400 Gel to reduce facial redness, bumps, and blemishes.
Interventions
- DRUG CGB-400
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2018-10-26 |
| Est. Completion | 2019-04-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04508205
The ClinicalTrials.gov registry entry for NCT04508205 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CAGE Bio, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CGB-400 is the first listed.
NCT04508205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04508205 about?
NCT04508205 is a clinical study titled "CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes". Open-label multicenter study using CGB-400 Gel to reduce facial redness, bumps, and blemishes.
What is the current status of trial NCT04508205?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2018-10-26. Estimated completion is 2019-04-18.
What interventions are being tested in trial NCT04508205?
The interventions under investigation include: CGB-400 (DRUG).
Who is sponsoring clinical trial NCT04508205?
This trial is sponsored by CAGE Bio, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.